A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

NCT06687980 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Lichen Simplex Chronicus

Interventions

DRUG: Dupilumab
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]